FDA approves Nuvo/Galderma's Pliaglis
This article was originally published in Scrip
Executive Summary
The US FDA has approved a supplemental new drug application for Pliaglis (lidocaine/tetracaine), Nuvo Research and Galderma's topical anaesthetic cream, having changed its mind since April when it issued a complete response letter for the drug.